R&D Fighting AMR with AI starts with data we can trust AMR Awareness Week asks the health community to take stock of where the fight against drug-resistant infections stands, and the picture is sobering.
News Mixed results for experimental Alzheimer's therapies at CTAD The CTAD Alzheimer's meeting hears encouraging data for new drug candidates from the likes of Biogen, AriBio, and BMS - but also some disappointments.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.